Kyowa Kirin Co Ltd (4151 JP)

Analysis

Health Care • Japan

Kyowa Hakko Kirin Co.,Ltd. develops, manufactures, and markets pharmaceuticals. The Company's products include a protein produced by genetic recombination technology, an anti-anemia agent that attaches new sugar chains through partial modification of the amino acid sequence of human erythropoietin (EPO), and a glycoprotein, human erythropoietin.

Refresh

Company Event • 06 Feb 2026 09:00 • Upcoming

Add To Calendar

Q4 2025

Company Event • 30 Oct 2025 16:50 • Upcoming

Add To Calendar

Q3 2025

Company Event • 01 Aug 2025 09:00 • Latest

Q2 2025

Company Event • 01 May 2025 16:00 • Upcoming

Add To Calendar

Q1 2025

Company Event • 07 Feb 2025 09:00 • Upcoming

Add To Calendar

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Q4 2025

Q3 2025

Q2 2025

Q1 2025

Q4 2024